LLY
$LLY
Eli Lilly and Company
Pharmaceutical heavyweight known for weight-loss drugs Mounjaro and Zepbound.
Healthcare$948.45
-26.51 (-2.72%)
Day Range$947.51 - $980.00
Prev Close$974.96
Analyst Rating
Strong Buy
30 Buy / 8 Hold / 1 Sell
Subscribers
9
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
LLY: Growth, GLP-1 Leadership & Valuation
Eli Lilly (LLY) delivered another solid EPS beat and remains a market leader in the fast-growing GLP-1/weight-loss market. Consensus is strongly positive and price targets imply meaningful upside, though competition and valuation are key risks heading into Q2 results.
May 9, 2026